journal
https://read.qxmd.com/read/38621249/correction-reducing-care-overuse-in-older-patients-using-professional-norms-and-accountability
#1
(no author information available yet)
No abstract text is available yet for this article.
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621248/rheumatology-what-you-may-have-missed-in-2023
#2
JOURNAL ARTICLE
Kafaf Jalali, Lisa A Mandl
Many patients with rheumatologic conditions receive care from physicians other than rheumatologists. Here we note key findings from 6 studies in rheumatology published in 2023 that offer valuable insights for internal medicine specialists and subspecialists outside of rheumatology. The first study investigated the effect of low-dose glucocorticoids on patients with rheumatoid arthritis (RA) over 2 years and challenged existing perceptions about the risks of glucocorticoids in this setting. The second study focused on the updated guideline for preventing and treating glucocorticoid-induced osteoporosis...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621247/what-you-may-have-missed-in-2023-keeping-up-with-the-constant-flow-of-new-medical-evidence
#3
JOURNAL ARTICLE
Alfonso Iorio, Christine Laine
No abstract text is available yet for this article.
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621246/infectious-diseases-what-you-may-have-missed-in-2023
#4
JOURNAL ARTICLE
Amena Alhammadi, Rasha Alshawaf, Swati Chavda, Sonya Ramondino, Mindy Schuster
In 2023, published research on COVID-19 remains prominent. The aim of this article is to highlight important developments in infectious disease evidence unrelated to COVID-19 that were published in 2023. The literature was screened for sound new evidence relevant to internal medicine specialists and subspecialists whose focus of practice is not infectious diseases. The highlighted publications relate to various organisms and patient populations. One article provides insight into the updated guidelines for the diagnosis and management of infective endocarditis...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621245/pulmonology-what-you-may-have-missed-in-2023
#5
JOURNAL ARTICLE
Aram Karkar, Sana Khan, Rebecca O'Leary, Albina Tyker, Michael Unger
The field of pulmonology saw significant advances in 2023. The publications highlighted in this article address advances and changes in practice related to asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pleural disorders, and sleep-disordered breathing. One article reviews data examining the efficacy of vaccination against respiratory syncytial virus, a respiratory viral illness that has had devastating effects globally. Four studies evaluate the role of various therapies in COPD, including dupilumab, ensifentrine, pulmonary rehabilitation programs, and lung volume reduction versus endobronchial valves...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621244/oncology-what-you-may-have-missed-in-2023
#6
JOURNAL ARTICLE
Courtney H Coschi, Lorin Dodbiba, DuPont Guerry
Advances in oncology treatment methods have improved outcomes and quality of life for patients with cancer. However, care of these patients can be complex, and the contribution of physicians from different specialties is crucial. This article highlights important publications from 2023 on topics across a wide spectrum relating to the management of oncology patients. The literature was screened for significant new evidence that is relevant to internal medicine specialists and subspecialists whose focus is not oncology...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621243/critical-care-what-you-may-have-missed-in-2023
#7
JOURNAL ARTICLE
Henry Ajzenberg, Mansor Abdalaziz N Binhashr, Mark Keith Hewitt, Michael Unger
Critical care medicine is a specialty that brings together a truly wide spectrum of patient populations, disease states, and treatment methods. This article highlights 10 important pieces of research from 2023 (and 1 from 2022) in critical care. The literature was screened for new evidence relevant to internal medicine physicians and hospitalists whose focus of practice is not critical care but who may be taking care of seriously ill patients. The articles highlight the diverse spectrum of pathology and interplay of various specialties that go into critical care...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621242/cardiology-what-you-may-have-missed-in-2023
#8
JOURNAL ARTICLE
Abdulrahman Alfraih, Achieng Tago, Michael Lacombe, William G Kussmaul
Cardiology and all its subspecialties continue to push the envelope in developing new treatment strategies for a wide variety of diseases. After screening more than 1300 articles, we highlight a selection of important cardiology articles published in 2023. Starting with prevention, we note articles that look at the effect of semaglutide in patients with obesity as well as a first-in-class drug, bempedoic acid, on cardiovascular outcomes. We have also examined new evidence comparing conservative management with invasive management of frail, older patients with non-ST-segment elevation myocardial infarction (NSTEMI)...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621241/gastroenterology-hepatology-what-you-may-have-missed-in-2023
#9
JOURNAL ARTICLE
Sama Anvari, Kayla Dadgar, Ciarán Galts, Michael Bretthauer
This article summarizes clinically important gastroenterology developments from 2023 for internal medicine specialists. In colorectal cancer screening, a new RNA fecal screening test is on the horizon, as well as a new analysis on the benefits of using artificial intelligence in screening colonoscopy to detect more polyps. There is new evidence for management of gastrointestinal bleeding, a new drug for treatment of recurrent small-intestinal angiodysplasia, and a new endoscopic treatment method in patients with gastrointestinal tumor bleeding...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621240/nephrology-what-you-may-have-missed-in-2023
#10
JOURNAL ARTICLE
Ali A M AlHabobi, Ashwaq M S Almutairi, Danah A S Y Bohemid, Ashwini R Sehgal
This article highlights a selection of important nephrology studies published in 2023 that have relevance for nonnephrologist physicians. Four studies examined progression of chronic kidney disease or cardiovascular disease with respect to finerenone use, magnesium supplementation, iron markers, and COVID-19. Two studies examined treatments to improve specific aspects of chronic kidney disease management, including daprodustat to address anemia and patiromer to address hyperphosphatemia. One study showed that acetazolamide added to loop diuretics increased diuresis in acute decompensated heart failure across a wide range of renal function...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588547/screening-for-colorectal-cancer
#11
REVIEW
Swati G Patel, Jason A Dominitz
Colorectal cancer (CRC) is the second leading cause of cancer death. Screening has been proven to reduce both cancer incidence and cancer-related mortality. Various screening tests are available, each with their own advantages and disadvantages and varying levels of evidence to support their use. Clinicians should offer CRC screening to average-risk persons aged 50 to 75 years; starting screening at age 45 years remains controversial. Screening may be beneficial in select persons aged 76 to 85 years, based on their overall health and screening history...
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588546/long-term-effect-of-salt-substitution-for-cardiovascular-outcomes-a-systematic-review-and-meta-analysis
#12
REVIEW
Hannah Greenwood, Katelyn Barnes, Justin Clark, Lauren Ball, Loai Albarqouni
BACKGROUND: Salt substitution is a simple yet increasingly promising strategy to improve cardiovascular outcomes. PURPOSE: To evaluate the long-term effects of salt substitution on cardiovascular outcomes. DATA SOURCES: PubMed, EMBASE, Cochrane CENTRAL, and CINAHL searched from inception to 23 August 2023. Trial registries, citation analysis, and hand-search were also done. STUDY SELECTION: Randomized controlled trials (RCTs) comparing provision of or advice to use a salt substitute with no intervention or use of regular salt among adults for 6 months or longer in total study duration...
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588545/trends-in-u-s-medical-cannabis-registrations-authorizing-clinicians-and-reasons-for-use-from-2020-to-2022
#13
JOURNAL ARTICLE
Kevin F Boehnke, Rachel Sinclair, Felicia Gordon, Avinash Hosanagar, Douglas R Roehler, Tristin Smith, Brooke Hoots
BACKGROUND: As medical cannabis availability increases, up-to-date trends in medical cannabis licensure can inform clinical policy and care. OBJECTIVE: To describe current trends in medical cannabis licensure in the United States. DESIGN: Ecological study with repeated measures. SETTING: Publicly available state registry data from 2020 to 2022. PARTICIPANTS: People with medical cannabis licenses and clinicians authorizing cannabis licenses in the United States...
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588544/how-would-you-manage-hiv-pre-exposure-prophylaxis-in-this-patient-with-medical-comorbidities-grand-rounds-discussion-from-beth-israel-deaconess-medical-center
#14
JOURNAL ARTICLE
Howard Libman, Douglas Krakower, Jessica L Taylor, Risa B Burns
Despite advances in treatment, HIV infection remains an important cause of morbidity and mortality, with more than 30 000 new cases diagnosed in the United States each year. There are several interventions traditionally used to prevent HIV transmission, but these vary in effectiveness and there are challenges to their implementation. In 2014, the Centers for Disease Control and Prevention published initial guidance on the use of antiretroviral pre-exposure prophylaxis (PrEP) to prevent transmission of HIV infection in persons at risk based on multiple studies that showed it to be highly efficacious in various populations...
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588543/a-salty-odyssey-a-potassium-enriched-journey-inspired-by-don-quijote
#15
JOURNAL ARTICLE
J Jaime Miranda, Cheryl A M Anderson, Kathy Trieu
No abstract text is available yet for this article.
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588542/annals-graphic-medicine-being-there
#16
JOURNAL ARTICLE
Travis Hoover
No abstract text is available yet for this article.
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588541/en-garde-or-on-board-travel-medicine-for-immunocompromised-patients-in-the-covid-19-era
#17
EDITORIAL
Christopher Radcliffe, Camille N Kotton
No abstract text is available yet for this article.
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588540/progressive-resistance-training-or-neuromuscular-exercise-for-hip-osteoarthritis-a-multicenter-cluster-randomized-controlled-trial
#18
JOURNAL ARTICLE
Troels Kjeldsen, Søren T Skou, Ulrik Dalgas, Lisa U Tønning, Kim G Ingwersen, Sara Birch, Pætur M Holm, Thomas Frydendal, Mette Garval, Claus Varnum, Bo M Bibby, Inger Mechlenburg
BACKGROUND: Exercise is recommended as first-line treatment for patients with hip osteoarthritis (OA). However, randomized controlled trials providing evidence for the optimal exercise type are lacking. OBJECTIVE: To investigate whether progressive resistance training (PRT) is superior to neuromuscular exercise (NEMEX) for improving functional performance in patients with hip OA. DESIGN: Multicenter, cluster-randomized, controlled, parallel-group, assessor-blinded, superiority trial...
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588539/annals-video-summary-long-term-effect-of-salt-substitution-for-cardiovascular-outcomes-a-systematic-review-and-meta-analysis
#19
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38560914/disparities-in-tuberculosis-incidence-by-race-and-ethnicity-among-the-u-s-born-population-in-the-united-states-2011-to-2021-an-analysis-of-national-disease-registry-data
#20
JOURNAL ARTICLE
Yunfei Li, Mathilda Regan, Nicole A Swartwood, Terrika Barham, Garrett R Beeler Asay, Ted Cohen, Andrew N Hill, C Robert Horsburgh, Awal Khan, Suzanne M Marks, Ranell L Myles, Joshua A Salomon, Julie L Self, Nicolas A Menzies
BACKGROUND: Elevated tuberculosis (TB) incidence rates have recently been reported for racial/ethnic minority populations in the United States. Tracking such disparities is important for assessing progress toward national health equity goals and implementing change. OBJECTIVE: To quantify trends in racial/ethnic disparities in TB incidence among U.S.-born persons. DESIGN: Time-series analysis of national TB registry data for 2011 to 2021. SETTING: United States...
April 2, 2024: Annals of Internal Medicine
journal
journal
20032
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.